Results 21 to 30 of about 711,467 (262)

Late-onset multivalvular carcinoid heart disease [PDF]

Arch Cardiol Mex
We present a 60-year-old man with an 11-year history of an ileocecal neuroendocrine tumor (NET) with a 1% proliferation index (Ki-67) and carcinoid syndrome (CS ...
Kristian Rivera, Marta Zielonka, Tania Ramírez Martínez, Nuria Pueyo‐Balsells, Diego Fernández-Rodríguez   +4 more
semanticscholar   +3 more sources

Managing end-stage carcinoid heart disease: A case report and literature review [PDF]

World J Gastrointest Oncol
BACKGROUND Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors, often diagnosed in an advanced stage when curative treatment is impossible and grueling symptoms related to vasoactive substance release by tumor cells affect patients’
Nikola Bulj, Vedran Tomašić, Maja Cigrovski Berković   +2 more
semanticscholar   +3 more sources

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers [PDF]

ESMO Open
Laura Algeri, Lovisa Falkman, Francesca Spada, Samuele Frassoni, V. Bagnardi, S. Boselli, Daniela Cardinale, Marco Zanobini, Joakim Crona, L. Benini, D. Tamayo, Cristina Mazzon, Lorenzo Gervaso, C.A. Cella, Maria Giulia Zampino, D. Ciardiello, Ashley Russo, Giuseppe Badalamenti, Staffan Welin, Nicola Fazio   +19 more
semanticscholar   +3 more sources

Carcinoid heart disease revealed by cyanosis with both right and left valvular involvement: a case report [PDF]

Journal of Medical Case Reports, 2018
Background Carcinoid heart disease is a frequent complication of carcinoid syndrome. It is related to the release by the carcinoid tumor and/or its metastases of bioactive substances such as serotonin.
Khadija Khay, Salim Arous, Tarik Bentaoune, Abdenasser Drighil, Rachida Habbal   +4 more
doaj   +2 more sources

Does Telotristat Have a Role in Preventing Carcinoid Heart Disease? [PDF]

Int J Mol Sci
Carcinoid heart disease (CHD) is a frequent and life-threatening complication in patients with carcinoid tumors. Its clinical management is challenging is some cases since serotonin-induced valve fibrosis leads to heart failure.
A. Herrera-Martínez, A. C. Fuentes-Fayos, R. Sánchez-Sánchez, Antonio J. Montero, André Sarmento-Cabral, M. Gálvez-Moreno, M. Gahete, Raúl M. Luque   +7 more
semanticscholar   +2 more sources

Prevalence, one-year-incidence and predictors of carcinoid heart disease [PDF]

Cardiovasc Ultrasound, 2023
Background Carcinoid heart disease (CHD) caused by neuroendocrine tumours (NET) is associated with an increased morbidity and mortality due to valvular dysfunction and right sided heart failure.
Isabel Mattig, M. Franke, R. Pschowski, A. Brand, K. Stangl, Fabian Knebel, H. Dreger   +6 more
semanticscholar   +2 more sources

Carcinoid Heart Disease: Early Outcomes after Surgical Valve Replacement in Nine Patients [PDF]

, 2018
Aim: To describe the early outcomes of carcinoid patients undergoing surgical heart valve replacement. Methods: In a retrospective study, records of patients with symptomatic carcinoid heart disease referred for valve surgery between 2012 and 2016 ...
Syed Saleem Mujtaba, Stephen Clark
openalex   +5 more sources

Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration [PDF]

Oncologist, 2023
Carcinoid heart disease (CaHD) is an important complication among patients with metastatic neuroendocrine tumors and carcinoid syndrome (CS). CS patients (25%-65%) eventually develop CaHD; these patients face a significantly increased risk of morbidity ...
Satya Das, Shannon Stockton, Saamir A Hassan   +2 more
semanticscholar   +2 more sources

Bioprosthetic valve monitoring in patients with carcinoid heart disease [PDF]

Front Cardiovasc Med, 2023
Background Carcinoid heart disease (CnHD) is a frequent cause of morbidity and mortality in patients with neuroendocrine tumors and carcinoid syndrome. Although valve replacement surgery appears to decrease all-cause mortality in patients with advanced ...
Kevin A. Honan, Saamir A Hassan, A. Deswal, J. Herrmann, Juhee Song, D. Monlezun, D. Halperin, A. Mahvash, A. Dasari, E. Koutroumpakis, M. Akay, D. Balanescu, I. S. D. de Armas, M. Patel, S. Nathan, B. Kar, K. Marmagkiolis, J. Lopez-Mattei, J. Patel, I. Gregoric, James Yao, Cezar A Iliescu   +21 more
semanticscholar   +2 more sources

Carcinoid Syndrome and Carcinoid Heart Disease as Manifestations of Non-Metastatic Ovarian Neuroendocrine Tumour

Acta Médica Portuguesa, 2017
The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves.
Joana Simões-Pereira, Lai Mun Wang, Attila Kardos, Ashley Grossman   +3 more
doaj   +3 more sources